申请人:John Wyeth & Brother Limited
公开号:US03965112A1
公开(公告)日:1976-06-22
The disclosure relates to derivatives of imidazoline of the general formula ##SPC1## Or pharmaceutically acceptable acid addition salts thereof wherein R.sup.3 and R.sup.4 which may be the same or different each represent hydrogen or lower alkyl, Ph represents phenyl, halophenyl, lower alkyl phenyl, di(lower alkyl) phenyl or lower alkoxy phenyl, R is hydroxyl, lower alkoxy or halogen, R.sup.1 is phenyl, halophenyl, lower alkyl phenyl, di(lower alkyl)phenyl, lower alkoxy phenyl or napthyl and R.sup.6 is hydrogen or lower alkyl. The compounds have hypoglycemic activity.
本公开涉及一般式为##SPC1##的咪唑啉衍生物或其药学上可接受的酸盐,其中R.sup.3和R.sup.4可以相同也可以不同,分别代表氢或低碳基,Ph代表苯基,卤代苯基,低碳基苯基,二(低碳基)苯基或低碳基氧基苯基,R代表羟基,低碳基氧基或卤素,R.sup.1代表苯基,卤代苯基,低碳基苯基,二(低碳基)苯基,低碳基氧基苯基或萘基,R.sup.6代表氢或低碳基。这些化合物具有降血糖活性。